Major Fat Injection (Lipofilling) — Cost, Top Hospitals & Success Rates | MyMedicPlus

Major fat injection — clinically termed lipofilling, autologous fat grafting, or structural fat grafting — is a surgical procedure in which a patient's own fat cells are harvested from an area of excess (such as the abdomen, flanks, or thighs), processed to remove blood and oil, and then meticulously reinjected to restore volume, improve contour, or correct deformity in a target area. Because the graft material is entirely the patient's own tissue, immunological rejection is not a concern and the results, when fat cells survive engraftment, are permanent.

Major fat injection is distinguished from minor or micro-fat grafting by the volume of fat transferred — typically exceeding 50–100 mL per session — and the anatomical targets involved, which may include the buttocks (Brazilian Butt Lift), breasts, face and temples, hands, and areas of reconstructive deficiency following tumour resection, trauma, or radiation injury. The technique has been substantially refined since Sydney Coleman's landmark work in the 1990s; today, standardised harvest, centrifugation, and multi-tunnel micro-droplet injection protocols achieve reliable, long-lasting volume restoration.

International centres in Thailand, South Korea, Turkey, and India perform high-volume lipofilling by plastic surgeons with specialised training, at costs 50–70% below those in the USA, UK, or Australia. The procedure's dual benefit — volume addition at the recipient site and modest contour improvement at the harvest site — makes it particularly popular for combined body contouring and facial rejuvenation plans.

Major fat injection addresses volume deficiency and contour irregularities across multiple anatomical regions:

• Facial ageing and volume loss: Temples, cheeks, nasolabial folds, lips, and periorbital hollowing — restoring youthful three-dimensional facial structure
• Breast augmentation and reconstruction: Primary breast volume enhancement in patients preferring an autologous approach; correction of implant-related defects; reconstruction after lumpectomy or mastectomy
• Gluteal augmentation (Brazilian Butt Lift — BBL): Enhancement of buttock projection, shape, and proportion using large-volume fat transfer
• Hand rejuvenation: Restoration of dorsal hand volume lost through ageing, covering extensor tendons and improving skin quality
• Body contouring defects: Correction of post-liposuction irregularities, lipodystrophy, Romberg's syndrome, and traumatic or surgical soft-tissue defects
• Radiation-related tissue damage: Fat grafting improves tissue quality and vascularity in irradiated fields; evidence supports benefit for chronic pain, fibrosis, and skin quality
• HIV-related facial lipoatrophy: Restoration of mid-facial volume in patients with antiretroviral-induced fat redistribution

Good candidates for major fat injection include patients who:

• Have adequate donor fat stores at a harvest site (abdomen, flanks, inner thighs, or arms)
• Seek natural, autologous volume restoration without synthetic implants or fillers
• Are in good general health with no conditions significantly impairing wound healing or fat cell survival
• Are non-smokers or have ceased smoking at least 4 weeks pre-operatively (nicotine impairs vascular ingrowth essential for fat survival)
• Have realistic expectations — fat retention varies between individuals (50–70% at 1 year), and a second session may be required
• Have stable body weight — significant post-operative weight loss will reduce the volume of the retained graft

Contraindications include:

• Insufficient donor fat: Extremely lean patients (BMI <18) may not have adequate harvestable fat
• Active infection at donor or recipient site
• Uncontrolled diabetes mellitus: Impairs wound healing and graft vascularisation
• Active or recent malignancy at the recipient site: Fat grafting to previously irradiated breast tissue requires careful oncological clearance; breast cancer survivors should be counselled based on individual circumstances
• Anticoagulation: Must be safely managed pre-operatively
• Unrealistic volume expectations without sufficient donor fat

The fat grafting procedure follows three core stages, with multiple technique variations at each step:

1. Fat Harvest: Donor fat is extracted by low-pressure liposuction using a blunt-tipped harvesting cannula (3–3.5 mm). The Coleman technique mandates gentle, low-vacuum aspiration (typically syringe-based) to minimise adipocyte trauma. Power-assisted liposuction (PAL) or water-jet-assisted liposuction (WAL/Body-Jet) are also used. Common donor sites are the periumbilical abdomen, flanks, inner thighs, and arms. The dual benefit of donor-site contouring is an advantage over synthetic alternatives.

2. Fat Processing: Harvested lipoaspirate must be processed to remove blood, oil, tumescent fluid, and cell debris before injection. The three principal methods are:

• Centrifugation (Coleman protocol): 3,000 rpm for 3 minutes; separates lipoaspirate into oil (top), purified fat (middle), and fluid/blood (bottom). The middle layer is used for injection. Currently the most validated technique
• Washing and decanting: Lipoaspirate is washed with saline and allowed to separate by gravity; simpler but less standardised
• Filtration (Puregraft system): Membrane filtration removes non-viable material; comparable outcomes to centrifugation with faster processing

3. Fat Injection: Processed fat is loaded into 1–3 mL syringes and injected through small-gauge blunt cannulas (1–2 mm) using a multi-plane, multi-tunnel, retrograde threading technique. Droplets of fat (0.1–0.3 mL per pass) are deposited throughout the recipient tissue in multiple anatomical planes to maximise contact between each fat droplet and surrounding vascularity — essential for graft survival (fat cells must be within 2 mm of a blood supply to survive). Over-injection is deliberately performed (10–30%) to account for expected resorption.

Advanced platforms — Nanofat and SVF-enriched fat grafting: Nanofat (mechanically emulsified fat) contains adipose-derived stromal cells and growth factors and is injected intradermally to improve skin quality. Stromal vascular fraction (SVF) enrichment uses enzymatic digestion to concentrate regenerative cells, potentially improving retention rates. These techniques remain areas of active research.

Major fat injection offers a unique combination of cosmetic and functional benefits:

• Permanent results: Successfully engrafted fat cells are permanent, unlike synthetic fillers that require repeated treatment every 6–24 months
• Autologous — no rejection, no allergy: Using the patient's own tissue eliminates the risk of allergic reaction or foreign body response
• Dual benefit: Simultaneous modest contour improvement at the harvest site (abdomen, thighs) while adding volume to the recipient area
• Natural texture and feel: Fat integrates seamlessly with surrounding tissues, producing results that look and feel natural
• Skin quality improvement: Research consistently demonstrates that fat grafting improves overlying skin quality, texture, and elasticity — attributed to the regenerative adipose-derived stromal cells contained within the graft
• Reconstruction capability: Can correct complex soft-tissue deficits including post-radiation damage, reconstructive irregularities, and congenital deformities
• Fat retention at 1 year: Standardised technique achieves approximately 50–70% graft retention at 12 months in experienced hands

Fat injection is generally well-tolerated, but the following complications are recognised:

• Fat resorption: Variable — 30–50% of injected fat is typically resorbed by 6–12 months, necessitating repeat sessions in some patients
• Contour irregularity: Uneven survival can produce lumps, nodules, or asymmetry; experienced technique minimises but does not eliminate this risk
• Oil cysts (liponecrotic pseudocysts): Non-viable fat undergoes liquefactive necrosis and forms oil-filled cysts; usually small and self-resolving, occasionally requiring aspiration
• Calcification: Fat necrosis can result in calcifications visible on mammography (relevant for breast fat grafting); these are distinguishable from malignant calcifications by an experienced radiologist but may complicate breast imaging surveillance
• Infection: Rare with appropriate antibiotic prophylaxis (<1%)
• Fat embolism (severe): Rare but potentially fatal complication, primarily associated with large-volume gluteal fat grafting (BBL) when fat is injected into or deep to the gluteal muscles. Injection restricted to the subcutaneous plane markedly reduces this risk; updated 2019 safety guidelines mandate subcutaneous-only injection for BBL
• Donor site complications: Haematoma, seroma, contour irregularity, or prolonged swelling at the liposuction donor site

Immediate post-operative period (Days 1–5): Swelling and bruising at both the donor and recipient sites are expected and are most pronounced during the first 72 hours. Compression garments are worn on donor sites (abdomen, flanks, thighs) for 4–6 weeks to reduce swelling and support skin retraction. Injected areas should not be compressed or massaged during the first 2–4 weeks to allow fat cell engraftment.

Week 1–2: Light activities may resume after 3–5 days. Patients avoid sitting directly on the buttocks (for BBL) for 2–6 weeks, using a specialised cushion that distributes weight onto the thighs. Strenuous exercise is prohibited for 3–4 weeks.

Months 1–3: Progressive subsidence of swelling reveals the underlying result. Significant volume reduction (resorption) will occur during this period. Final assessment of retained volume is deferred until 3–6 months post-operatively to allow the graft to fully consolidate.

Months 3–6: Stable result is assessed. If additional volume is desired, a planned second session may be performed — commonly practised in facial fat grafting and breast lipofilling. Many surgeons over-correct at the first session by 20–30% to anticipate resorption.

Follow-up schedule:

• Day 7–10: Wound review and compression garment assessment
• Week 6: Activity clearance; donor site scar management
• Month 3: Volume assessment; planning of second session if needed
• Month 6 and 12: Long-term result review and photography

The cost of major fat injection varies by treated area, volume injected, and country. Approximate cost ranges for a single session are:

• United States: USD 5,000–15,000 (facial lipofilling); USD 8,000–20,000 (BBL or breast lipofilling)
• United Kingdom: GBP 5,000–12,000
• Australia: AUD 7,000–18,000
• South Korea: USD 3,000–8,000
• Turkey: USD 2,000–6,000 — particularly popular for BBL combined with liposuction
• Thailand: USD 2,500–7,000
• India: USD 1,500–5,000 at accredited facilities

Costs are significantly influenced by: the number of anatomical areas treated, total fat volume harvested and injected, concurrent procedures (facelift, liposuction, implants), anaesthesia type and duration, and whether advanced processing (SVF enrichment, PRP addition) is employed. Medical tourism packages in India and Turkey often include accommodation, airport transfer, and all-inclusive surgical care.

• Hyaluronic acid dermal fillers (e.g., Juvederm, Restylane): For facial volume — immediate results, reversible with hyaluronidase; require repeat treatment every 6–18 months; not suitable for large-volume body augmentation
• Poly-L-lactic acid (Sculptra): Biostimulator injected in multiple sessions to gradually build collagen and volume; results last 2+ years; most suitable for facial ageing
• Silicone implants (breast, buttock, calf): Provide predictable, permanent volume; do not rely on fat retention; carry distinct risks including capsular contracture, implant rupture, and displacement
• Calcium hydroxylapatite (Radiesse): Semi-permanent filler effective for hand rejuvenation and mid-face volume; lasts 12–18 months; not reversible
• Non-surgical body contouring (CoolSculpting, EMSCULPT): Removes fat from donor areas non-invasively but does not add volume to recipient sites; may complement fat grafting planning